Week In Review: Insilico Signs Six-Drug AI Discovery Deal With Sanofi Worth Up To $1.2 Bln
Insilico Medicine signed a six-drug research collaboration with Sanofi. Wuhan Neurophth announced a $140 mn agreement to use Cyagen’s AI platform to discover novel AAV vectors.
Source: seekingalpha.com